Association of DLG5 R30Q variant with inflammatory bowel disease

被引:58
|
作者
Daly, MJ
Pearce, AV
Farwell, L
Fisher, SA
Latiano, A
Prescott, NJ
Forbes, A
Mansfield, J
Sanderson, J
Langelier, D
Cohen, A
Bitton, A
Wild, G
Lewis, CM
Annese, V
Mathew, CG
Rioux, JD
机构
[1] MIT, Broad Inst, Cambridge, MA 02139 USA
[2] Harvard Univ, Cambridge, MA 02139 USA
[3] Guys Kings & St Thomas Sch Med, Dept Med & Mol Genet, London, England
[4] IRCCS Hosp, CSS, San Giovanni Rotondo, Italy
[5] St Marks Hosp, Harrow, Middx, England
[6] Univ Newcastle Upon Tyne, Dept Gastroenterol & Hepatol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[7] Guys & St Thomas Hosp, Dept Gastroenterol, London SE1 9RT, England
[8] Montreal Jewish Gen Hosp, Montreal, PQ, Canada
[9] Ctr Hosp Sherbrooke, Sherbrooke, PQ, Canada
[10] McGill Univ, Ctr Hlth, Dept Gastroenterol, Montreal, PQ, Canada
基金
英国惠康基金;
关键词
IBD; DLG5; association; R30Q;
D O I
10.1038/sj.ejhg.5201403
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Crohn's disease (CD) and ulcerative colitis (UC) are chronic inflammatory diseases of the gastrointestinal system known as the inflammatory bowel diseases (IBD). Recently, Stoll and colleagues reported a novel finding of genetic variation in the DLG5 gene that is associated with IBD (CD and UC combined). We present here a study of the genetic variation described in that report in two well-powered, independent case-control cohorts and one family-based collection, and confirm the proposed association between IBD and the R30Q variant of DLG5 in two of the three studies. We are, however, unable to replicate the other proposed association to the common haplotype described in Stoll et al and suggest that this other finding could conceivably have been partially a statistical fluctuation and partially a result of LD with the replicated R30Q association. This study provides support for the hypothesis that DLG5 constitutes a true IBD risk factor of modest effect.
引用
收藏
页码:835 / 839
页数:5
相关论文
共 50 条
  • [21] Association of DLG5 and inflammatory bowel disease across populations - Reply
    Tenesa, A
    Noble, C
    Satsangi, J
    Dunlop, M
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2006, 14 (03) : 261 - 261
  • [22] Analysis of the contribution of Dlg5 in inflammatory bowel disease
    Noble, CL
    Nimmo, ER
    Drummond, H
    Smith, L
    Arnott, ID
    Satsangi, J
    GASTROENTEROLOGY, 2005, 128 (04) : A446 - A446
  • [23] DLG5 R30Q is not associated with IBD in Hungarian IBD patients but predicts clinical response to steroids in Crohn's disease
    Lakatos, PL
    Fischer, S
    Claes, K
    Kovacs, A
    Molnar, T
    Altoijay, I
    Demeter, P
    Tulassay, Z
    Palatka, K
    Papp, M
    Rutgeerts, P
    Szalay, F
    Papp, J
    Vermeire, S
    Lakatos, L
    INFLAMMATORY BOWEL DISEASES, 2006, 12 (05) : 362 - 368
  • [24] Genetic variation in DLG5 is associated with inflammatory bowel disease
    Stoll, M
    Corneliussen, B
    Costello, CM
    Waetzig, GH
    Mellgard, B
    Koch, WA
    Rosenstiel, P
    Albrecht, M
    Croucher, PJP
    Seegert, D
    Nikolaus, S
    Hampe, J
    Lengauer, T
    Pierrou, S
    Foelsch, UR
    Mathew, CG
    Lagerstrom-Fermer, M
    Schreiber, S
    NATURE GENETICS, 2004, 36 (05) : 476 - 480
  • [25] Genetic variation in DLG5 is associated with inflammatory bowel disease
    Monika Stoll
    Brit Corneliussen
    Christine M Costello
    Georg H Waetzig
    Bjorn Mellgard
    W Andreas Koch
    Philip Rosenstiel
    Mario Albrecht
    Peter J P Croucher
    Dirk Seegert
    Susanna Nikolaus
    Jochen Hampe
    Thomas Lengauer
    Stefan Pierrou
    Ulrich R Foelsch
    Christopher G Mathew
    Maria Lagerstrom-Fermer
    Stefan Schreiber
    Nature Genetics, 2004, 36 : 476 - 480
  • [26] Investigation of association of the DLG5 gene with phenotypes of inflammatory bowel disease in the British population
    Alexandra V. Pearce
    Sheila A. Fisher
    Natalie J. Prescott
    Clive M. Onnie
    Reenal Pattni
    Peter Green
    Alastair Forbes
    John Mansfield
    Jeremy Sanderson
    Stefan Schreiber
    Cathryn M. Lewis
    Christopher G. Mathew
    International Journal of Colorectal Disease, 2007, 22 : 419 - 424
  • [27] Investigation of association of the DLG5 gene with phenotypes of inflammatory bowel disease in the British population
    Pearce, Alexandra V.
    Fisher, Sheila A.
    Prescott, Natalie J.
    Onnie, Clive M.
    Pattni, Reenal
    Green, Peter
    Forbes, Alastair
    Mansfield, John
    Sanderson, Jeremy
    Schreiber, Stefan
    Lewis, Cathryn M.
    Mathew, Christopher G.
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2007, 22 (04) : 419 - 424
  • [28] The contribution of the DLG5 113A variant in early-onset inflammatory bowel disease
    Russell, R. K.
    Drummond, H. E.
    Nimmo, E. R.
    Anderson, N.
    Wilson, D. C.
    Gillett, P. M.
    McGrogan, P.
    Hassan, K.
    Weaver, L. T.
    Bisset, W. M.
    Mahdi, G.
    Satsangi, J.
    JOURNAL OF PEDIATRICS, 2007, 150 (03): : 268 - 273
  • [29] Gender-stratified analysis of DLG5 R30Q in 4707 patients with Crohn disease and 4973 controls from 12 Caucasian cohorts
    Browning, B. L.
    Annese, V.
    Barclay, M. L.
    Bingham, S. A.
    Brand, S.
    Buening, C.
    Castro, M.
    Cucchiara, S.
    Dallapiccola, B.
    Drummond, H.
    Ferguson, L. R.
    Ferraris, A.
    Fisher, S. A.
    Gearry, R. B.
    Glas, J.
    Henckaerts, L.
    Huebner, C.
    Knafelz, D.
    Lakatos, L.
    Lakatos, P. L.
    Latiano, A.
    Liu, X.
    Mathew, C.
    Mueller-Myhsok, B.
    Newman, W. G.
    Nimmo, E. R.
    Noble, C. L.
    Palmieri, O.
    Parkes, M.
    Petermann, I.
    Rutgeerts, P.
    Satsangi, J.
    Shelling, A. N.
    Siminovitch, K. A.
    Toeroek, H.-P.
    Tremelling, M.
    Vermeire, S.
    Valvano, M. R.
    Witt, H.
    JOURNAL OF MEDICAL GENETICS, 2008, 45 (01) : 36 - 42
  • [30] Reply to Tenesa et al ‘Association of DLG5 and inflammatory bowel disease across populations’
    Mark J Daly
    John D Rioux
    European Journal of Human Genetics, 2006, 14 : 260 - 261